Elevated preoperative hemoglobin A1C is linked to higher postoperative complications in general surgery. 36% of patients had diagnosed diabetes; 6.4% had undiagnosed diabetes with A1C levels indicating the condition. Complications risk increased with A1C levels: from 1.06 for <6.0% to 1.32 for >9.0%. Undiagnosed diabetes led to 24% higher mortality risk and 11% higher risk […]
Author: STITCHES Newsletter
Social Factors Impact Post-Gastrectomy Outcomes in Cancer Patients
Social determinants significantly affect short-term outcomes after gastrectomy for gastric adenocarcinoma, highlighting disparities in care. Black patients are 25% less likely and Hispanic patients are 29% less likely to experience extended hospital stays compared to white patients. Higher education levels correlate with a 19% increased risk of extended stays and a 26% increased risk of […]
Bile Duct Injury Repair Insights: Delayed is Safer
Delayed repair for bile duct injuries (BDIs) following cholecystectomy significantly lowers reoperation and mortality rates. Early repair increases reoperation rates by 3.31 times and stricture rates by 7.41 times compared to late repair. Non-operative management leads to a staggering 16.60 higher reoperation rate than operative interventions. Surgeons should prioritize delayed repair to improve patient outcomes […]
Early FAST Ultrasound Cuts Trauma Mortality in Low-Resource Settings
Using early FAST ultrasound drastically lowers mortality rates in severe trauma patients, proving essential in low-resource environments. In-hospital mortality: 39.2% with FAST vs. 66.2% without (p=0.001). Thirty-day mortality: 45.6% with FAST vs. 72.7% without (p=0.001). Integrating FAST into trauma triage can enhance surgical outcomes significantly. Reduced CT scans (82.5% with FAST vs. 96.1% without, p=0.006) […]
Multimodal Advances Transforming Gastric Cancer Management
Recent updates in multimodal treatment are reshaping gastric cancer care, impacting surgical strategies and patient outcomes. Laparoscopic and robotic gastrectomy are now standard in Asia, supported by major trials like JCOG0912 and K-LASS02. The FLOT chemotherapy regimen is becoming the global standard, while SOX and XELOX gain traction in Asia. Surgeons should consider integrating immunotherapy […]
Efficacy of HIPEC After Laparoscopic Gastrectomy in Gastric Cancer
Laparoscopic gastrectomy plus hyperthermic intraperitoneal chemotherapy (HIPEC) improves outcomes for gastric cancer patients with positive peritoneal lavage cytology. HIPEC-treated patients had significantly lower postoperative recurrence (66.7% vs. 90.9%) and visible metastasis (29.6% vs. 59.1%, p < 0.05). 3-year overall survival for HIPEC patients was 51.8% versus 18.2% for non-HIPEC (p = 0.005). Consider HIPEC for […]
Fluorescence Imaging with ICG Reduces Colorectal Leaks
Fluorescence imaging using indocyanine green significantly improves surgical outcomes in colorectal procedures. It reduces anastomotic leak rates with an odds ratio of 0.58 (95% CI 0.44-0.75). It enhances lymph node retrieval by an average of 6.32 nodes in gastrointestinal cancer surgeries (95% CI 4.43-8.22). Intraoperative adjustments to transection points are feasible, improving surgical precision. Evidence […]
Streamlined Robotic Training Cuts Time, Maintains Mastery
A refined robotic surgical training curriculum enhances skill acquisition while significantly lowering training time. Mastery rates jumped from 83% to 100% with the new curriculum. Mean console training time decreased from 7 hours to 5 hours and 42 minutes (p=0.005). This efficient approach offers general surgery residents a more effective pathway to proficiency. Median VR […]
New predictive models identify risks for liver tumor rupture
Understanding the risk factors for hepatocellular carcinoma (HCC) rupture can improve surgical outcomes. Key risk factors include cirrhosis, protrusion ratio, and maximum tumor length. The new capture nomogram achieved AUC values of 0.857, 0.824, and 0.840 across training, validation, and test groups, indicating high predictive accuracy. Using these models can enhance early risk assessment and […]
One-stage surgery beats two-stage for unresectable liver metastases.
Median overall survival was 46.5 months for one-stage versus 34.0 months for two-stage (p = 0.043). Complication rates were similar: 11% for one-stage and 13% for two-stage (p = 0.567). Local treatment was more successful with one-stage surgery, achieving complete resection or ablation in 52 patients compared to 29 in the two-stage group (p < […]